
Sign up to save your podcasts
Or
U.S. Government funding for scientific research has led to innovations and breakthroughs for decades. But, with funding freezes, slashed budgets, and the cancellation of grants, the health of America’s scientific enterprise is in jeopardy. What’s at stake – for research, innovation, and the economy? How did we get here, and what will it take to chart a more sustainable path forward? David Leonhardt, director of the Editorial Board of The New York Times, leads a discussion with Holden Thorp, editor in chief of the Science family of journals, Jennifer Nuzzo, epidemiology professor at Brown University, and Karel Mertens, senior vice president at the Federal Reserve Bank of Dallas. Their conversation was held in late June, 2025.
4.2
229229 ratings
U.S. Government funding for scientific research has led to innovations and breakthroughs for decades. But, with funding freezes, slashed budgets, and the cancellation of grants, the health of America’s scientific enterprise is in jeopardy. What’s at stake – for research, innovation, and the economy? How did we get here, and what will it take to chart a more sustainable path forward? David Leonhardt, director of the Editorial Board of The New York Times, leads a discussion with Holden Thorp, editor in chief of the Science family of journals, Jennifer Nuzzo, epidemiology professor at Brown University, and Karel Mertens, senior vice president at the Federal Reserve Bank of Dallas. Their conversation was held in late June, 2025.
1,220 Listeners
3,935 Listeners
38,470 Listeners
21,958 Listeners
43,701 Listeners
6,696 Listeners
4,660 Listeners
58 Listeners
2,327 Listeners
32,365 Listeners
29 Listeners
7,074 Listeners
16,238 Listeners
3 Listeners
0 Listeners
5 Listeners
16,225 Listeners
33 Listeners
1,549 Listeners
3,406 Listeners